Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Green Plains (GPRE) EPS (Weighted Average and Diluted) (2017 - 2026)

Green Plains filings provide 12 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.19 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 122.09% to $0.19 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.87, a 37.5% decrease, with the full-year FY2025 number at -$1.8, down 39.53% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.19 in Q4 2025 for Green Plains, up from $0.17 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.73 in Q2 2022 to a low of -$1.27 in Q3 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.67 (2022), compared with a mean of -$0.44.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 265.0% in 2022 and later tumbled 816.67% in 2024.
  • Green Plains' EPS (Weighted Average and Diluted) stood at -$0.14 in 2021, then plummeted by 378.57% to -$0.67 in 2022, then skyrocketed by 117.91% to $0.12 in 2023, then tumbled by 816.67% to -$0.86 in 2024, then surged by 122.09% to $0.19 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.19 (Q4 2025), $0.17 (Q3 2025), and -$1.09 (Q2 2025) per Business Quant data.